cro.directory
← Compare landing

PSI vs Ergomed Clinical Research

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/appian/medsource

CategoryPSIErgomed Clinical Research
Listed sitecrocro
SummaryPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.
Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Regulatory Affairs
Modalities
  • Cell Therapy
  • Gene Therapy
  • Radiopharmaceutical
  • Small Molecule
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
Indications
  • Oncology
  • Gastroenterology
  • Neurology
  • Infectious Disease
  • Respiratory
  • Immunology
  • Cardiovascular
  • Nephrology
  • Metabolic
  • Oncology
  • Rare Disease
Locations
  • Osaka, Osaka, Osaka, Japan
  • Headquarters, Raleigh, North Carolina, United States
  • Operational Hub, Boston, Massachusetts, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.